Click here to view next page of this article
Menopause
Definition
Permanent cessation of menstruation due to low endogenous estrogen production
EtiologyLack of ovarian follicular development despite increased gonadotropin stimulation
EffectHypoestrogenism - an endocrine deficiency
Perimenopausal Healthy Women with Uterus
Optimal treatment is low dose OCSwitch to HRT when FSH T& E2
Urogenital Symptoms Associated with Menopause | |
Urinary | Genital |
Frequency | Irritation |
Urgency | Burning |
Nocturia | Leukorrhea |
Incontinence |
Dyspareunia
Decreased vaginal secretions Shortening/lessening of vaginal distensibility |
Effects of Short-Term ERT on the Urogenital Tracts |
Restores glycogen disposition |
Promotes return of normal pH and bacterial flora |
Reduces recurrent urinary tract infections |
Improves urethral function, including strengthening muscle contractility and tone |
Reduces urinary incontinence |
Improves vaginal blood flow |
Skeletal Changes after Menopause
Cortical Bone - 80% (limbs)Trabecular Bone - 20% (spine & distal radius)
Postmenopausal bone loss occurs for 15 yrs
Trabecular bone: 5%/yr
Cortical bone: 1-2%/yr
Postmenopausally
Trabecular bone 4, 50%
Cortical bone ,I, 30%
Demography of Osteoporosis in U.S. Women n ~ 20 million
Annual incidence Fx = 1.2 millionVertebral Fx ~ 600,000/year
Hip Fx 200,000/yr
Mortality 10%
Nursing home - 150,000Health care costs " $6 billion/year
Postmenopausal Bone Loss
Etiology Rate bone resorption
ERT: Rate bone resorption
Stabilizes bone mass
Bone formation unchanged
Stopping ERT results in Bone Loss
Need ERT >5 yrs to Fx
Should take ERT >15 yrs
Major CHD in Nurses Health Study
Follow up Study 60,000 PM Women
Risk of CHD in Current HRT Users According to Dose of Estrogen
Estrogen replacement Therapy/CHD
Angiographic Studies
Mechanisms of Cardioprotection by ERT
1. Altering lipid profile
2. Arterial blood flow
3. Antioxidant activity
4. N.O. endothelial synthesis
5. Acetylcholine reversal
6. ACE activity
Meta-Analysis of HRT and Risk of Colorectal Cancer
Use of Postmenopausal ERT Increases Life Span of Women
Retards development of atherosclerosis (~MI)Reduces incidence of senile dementia (A.D.)
Lowers risk of hip fractures
Reduces Incidence of colorectal cancer
Increased survival rates after breast cancer dx (indirect)
What should Clinicians Tell Women About Exogenous Estrogen and Breast Cancer Today
Analysis of vast amount of epidemiologic data indicates exogenous estrogen in OCs does not Initiate breast cancer in women.Exogenous estrogen can stimulate growth of occult breast cancer. This action Increases likelihood of early diagnosis and permanent cure.